H.R. 4640 · 116th Congress

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019

Stage
In committee
Introduced
2019-10-11
Latest action
2019-10-14 · Referred to the Subcommittee on Health.

Summary

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.